Literature DB >> 7558894

Characterization of cells containing factor XIII subunit a in benign and malignant buccal lesions.

M Toida1, Y Okumura, K K Swe Win, N Oka, T Takami, R Adány.   

Abstract

In the present study, the distribution pattern and characteristics of cells containing Factor XIII subunit a (FXIII A) have been studied in benign and malignant lesions of human buccal mucosa. Tissues from four irritation fibromas and three squamous cell carcinomas were studied by means of double immunofluorescent staining techniques in which the detection of FXIII A was combined with a reaction with CD14 (recognizing a monocyte/macrophage differentiation marker antigen), Mac 387 (reacting with a special subset of macrophages), anti-HLA-DR, Ki-M7 (labelling phagocytosing macrophages) or Ki-67 (visualizing a nuclear antigen associated with cell proliferation) monoclonal antibodies. FXIII A was detected in cells of the connective tissue stroma in both benign and malignant buccal lesions. The number of these FXIII A-reactive cells (FXIII A+ cells) increased considerably in the tumour tissues, in particular in those surrounding tumour cell clusters. FXIII A+ cells scattered in the fibromatous tissues were spindle-shaped, whereas in the tumour stroma, large stellate cells predominated, and round cells were likewise labelled around blood vessels. FXIII A+ cells were labelled with CD14 and Ki-M7 in both fibromatous and tumoural buccal mucosa; however, they failed to show any reaction with Ki-67. FXIII A+ cells accumulated in the tumour stroma reacted for HLA-DR as well. These results indicate that in both the benign and malignant buccal lesions FXIII A is contained in a subpopulation of tissue macrophages, which represents a monocyte-derived (CD14+) and phagocytosing (Ki-M7+) cell population. The accumulation of the FXIII A+ cells in the tumour stroma is believed to be a result of direct migration from the circulating blood.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7558894

Source DB:  PubMed          Journal:  Histochem J        ISSN: 0018-2214


  32 in total

1.  Cross-linking of a major fibroblast surface-associated glycoprotein (fibronectin) catalyzed by blood coagulation factor XIII.

Authors:  J Keski-Oja; D F Mosher; A Vaheri
Journal:  Cell       Date:  1976-09       Impact factor: 41.582

2.  Cross-linking of fibronectin to collagen by blood coagulation Factor XIIIa.

Authors:  D F Mosher; P E Schad
Journal:  J Clin Invest       Date:  1979-09       Impact factor: 14.808

3.  Factor XIIIa is expressed by fibroblasts in fibrovascular tumors.

Authors:  A J Nemeth; N S Penneys
Journal:  J Cutan Pathol       Date:  1989-10       Impact factor: 1.587

Review 4.  Pathogenesis of tumor stroma generation: a critical role for leaky blood vessels and fibrin deposition.

Authors:  J A Nagy; L F Brown; D R Senger; N Lanir; L Van de Water; A M Dvorak; H F Dvorak
Journal:  Biochim Biophys Acta       Date:  1989-02

5.  Cross-linking of fibronectin to collagenous proteins.

Authors:  D F Mosher
Journal:  Mol Cell Biochem       Date:  1984       Impact factor: 3.396

6.  Fibrinolysis resistant fibrin deposits in lymph nodes with Hodgkin's disease.

Authors:  R Adány; A Szegedi; R J Ablin; L Muszbek
Journal:  Thromb Haemost       Date:  1988-10-31       Impact factor: 5.249

7.  Growth regulation of fibroblasts by thrombin, factor XIII and fibronectin.

Authors:  H D Bruhn; J Pohl
Journal:  Klin Wochenschr       Date:  1981-02-02

8.  Growth regulation of vessel wall cells and of tumor cells by thrombin, factor XIII and fibronectin.

Authors:  H D Bruhn
Journal:  Thromb Haemost       Date:  1981-12-23       Impact factor: 5.249

9.  Demonstration of factor XIII in human megakaryocytes by a fluorescent antibody technique.

Authors:  T H Kiesselbach; R H Wagner
Journal:  Ann N Y Acad Sci       Date:  1972-12-08       Impact factor: 5.691

10.  Factor XIII cross-linking of fibronectin at cellular matrix assembly sites.

Authors:  E L Barry; D F Mosher
Journal:  J Biol Chem       Date:  1988-07-25       Impact factor: 5.157

View more
  1 in total

1.  Demonstration of TGF-β and XIIIα in Endocardial Biopsies of Carcinoid Heart Disease Patients: an Immunofluorescence Study.

Authors:  Dorgrit Diepholz; Andreas Wilke; Bernhard Maisch; Dietmar Steverding
Journal:  Cardiol Res       Date:  2011-05-20
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.